Navigation Links
Transgenomic Reports Second Quarter 2008 Results
Date:8/5/2008

novel research efforts is our recently announced SEAL technology, or SURVEYOR(R) Endonuclease Adaptor-ligated Libraries (SEAL). This cost-effective and high-throughput enabling technology for whole genome analysis evolved from our highly sensitive SURVEYOR Nuclease mutation detection technology. SEAL will prove extremely useful for whole genome sequence analyses and a host of key mutation and variation analyses of specific gene targets which positions this technology to change the shape of pharmacogenomic research and patient assessment. With the possibility to reduce the cost of whole genome analysis to under $10,000, SEAL could impact the use of DNA sequencing within pharmacogenomic assessments for personalized medicine. We are confident that SEAL and other assays under development or in licensing discussions will continue to create valuable opportunities to expand our services as well as the depth and breadth of our third-party collaborations."

Earnings Call

Company management will discuss second quarter 2008 financial results via teleconference on Wednesday, August 6, at 8:30 AM Eastern Time. To access the call via telephone, dial 800-895-1085 or 785-424-1055. The Company will also host a live broadcast of the call over the Internet. To listen to the webcast, investors should log on to the Company's Investor Relations web page at http://www.transgenomic.com/events.asp?id=6 and follow the instructions provided. An archived recording of the conference call will be available and can be accessed via the web using the same link listed above for 14 days after the call. Investors can also listen to a replay via telephone until 11:59 p.m. Eastern Time on Wednesday, August 20, 2008. Simply dial 800-388-9064 or 402-220-1116 from any telephone.

About Transgenomic

Transgenomic (OTC-Bulletin Board: TBIO) is a global biotechnology company specializing in high sensitivity genet
'/>"/>

SOURCE Transgenomic
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Transgenomic, Inc. Reports Second Quarter 2007 Results
2. Webcast Alert: Transgenomic Inc. Announces Third Quarter 2007 Earnings Release Conference Call Webcast
3. Transgenomic, Inc. Forms Scientific Advisory Board
4. Transgenomic Appoints David Pauluzzi to Board of Directors
5. Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
6. Reminder Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
7. Transgenomic Opens Pharmacogenomics Laboratory in China
8. Webcast Alert: Transgenomic Inc. Announces First Quarter 2008 Earnings Release Conference Call Webcast
9. Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation
10. Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
11. Reminder: Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... A mechanised blue dye test alternative is hel...y assurance one step closer for pharma-companies. ... machine developed by Sepha for use with bliste...al local and global pharma-companies such as Sanof...rance and productivity improvements on the packagi...
(Date:11/25/2009)....25/PRNewswire/--ResearchTrianglePark-basedCnanozI...ntwaterpurificationsystemNanoPure(TM)developedfrom...rSupply,Hon.MinisterViswarupandotherleadersinHyder...ituteofTechnology(IIT)Kanpur,confirmedthatthemajor...sthatcanbeextremelyhazardoustohumanhealth. ,, T...
(Date:11/25/2009)... Ambassador to Speak at Economic Club of Canada ... November 25, 2009 -- Ambassador to Speak at Econo...ench Ambassador for International Investment, and ...o view a biography of David Appia go to www.inves...vailable to meet with press to discuss recent pro-...
(Date:11/25/2009)...25/PRNewswire/-Cytochromatodayannouncedtheappointm...illreplaceMr.UlrikSporkastheNovoA/Srepresentativeo...nchangedatsixmembers. ,, "Weareverypleasedtowel...fromhisexperienceandguidanceasCytochromacontinuest...ypharmaceuticalcompany,"statedAlanLewis,PhD,Chairm...
Breaking Biology Technology:Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2French Ambassador for International Investment to Visit Toronto December 11 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2
...therlands, January 22 Progentix,Orthobiology B.V....cing,Round. The round was led by BioGeneration Ven...ed in 2007 and develops a,unique suite of osteoind...in bone regenerative surgery. Progentix bone graft...iomaterial scaffolds that have the ability to,attr...
... Jan. 21 VNUS(R) Medical,Technologies, Inc. (Nasd...,for the minimally invasive treatment of periphera...o report its financial results for the,fourth quar...rket on,February 7., VNUS plans to host its regul... p.m. ET on February 7. This call will be webcast ...
...mbines first approved direct renin inhibitor with ... a single tablet - Data show combination of Tektu...blood pressure reductions compared to either drug ... most require two or more, medicines - single-ta... number of pills patients take, ...
Other Biology Technology:Progentix Orthobiology B.V. Closes Series A Financing Round 2VNUS Medical Technologies to Report Fourth-Quarter 2007 Results and Webcast Teleconference on February 7 2Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 2Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 3Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 4Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 5
(Date:11/26/2009)...itehead researchers have developed a new type of g... genes and proteins used by pathogens, according t... cultures genes are present in two copies: one inh...ne inactivation by mutation is therefore inefficie...d copy usually remains active and takes over. , ...
(Date:11/25/2009)...ch, may be used to boost resistance to, or slow, t... of Medicine researchers report in a study publish...ce . , Parkinson,s disease is caused by a degene...ain known as the substantia nigra, which is respon... of dopamine in late-stage Parkinson,s causes symp...
(Date:11/25/2009)...the linchpin of the environment, where atmosphere,...ny students see soil as "just dirt" a place to gr...s are challenged with the task of helping students...of soil in the environment. , A collaborative p...at University of Nebraska-Lincoln, Oregon State Un...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2For peats sake 3A Alternative growing media 9796 1For peats sake 3A Alternative growing media 9796 2Blue Cross Blue Shield of Georgia Offers The Healing Book to Help Young Life Insurance Beneficiaries Cope with Losing a Loved One 56276 1Blue Cross Blue Shield of Georgia Offers The Healing Book to Help Young Life Insurance Beneficiaries Cope with Losing a Loved One 56276 2Fruit Even Healthier Than Thought 3A Study 56271 1
...atory birds choose the nesting location of their f...ry in the bird world. But a new University of Mar...suggests that the environmental conditions the bir...re they breed for the rest of their lives, a facto...s climate change makes their winter habitats hotte...
...EBRUARY 11, 2008 -- Transgenic cotton cultivars we...007. Transgenic cultivars with pest-managing trait... lint and seed, while the expressed propriety trai.../or enable use of broad-spectrum herbicides for we...reasing number of cultivars and an increasingly di...
...st strips buffering rivers and streams of the Amaz...he current legal requirement, according to pioneer...f East Anglia (UEA). , Published in the journal C... wildlife study in remnant riparian tropical fores...rently requires that all forest strips alongside r...
Other Biology News:Early environment may be key to determining bird migration location 2Early environment may be key to determining bird migration location 3Is transgenic cotton more profitable? 2Amazon corridors far too narrow, warn scientists 2
Normal Chicken Serum from Equitech-Bio
Pig Serum Non-Sterile Trace-Hemolyzed from Pel-Freez Biologicals
Mouse Anti-Keap1 Monoclonal Antibody, Unconjugated, Clone 333116 from R&D Systems
Normal Guinea Pig Serum from Equitech-Bio
Biology Products: